Literature DB >> 14606718

Cigarette smoking-induced acute eosinophilic pneumonia showing tolerance in broncho-alveolar lavage findings.

Yoshihiro Kitahara1, Kae Matsumoto, Yasuyuki Taooka, Chie Moritani, Kenji Nakamura, Nobuyuki Ohashi, Kazuhiro Daido, Ken-ichi Arita.   

Abstract

A 19-year-old man was admitted due to acute respiratory failure. He had started cigarette smoking (CS) about three weeks prior to onset. Multiple nodular shadows and patchy infiltrations were found on chest computed tomography. His respiratory state improved promptly by intravenous methylprednisolone. He resumed CS soon after discharge without any symptoms. We suspected CS-induced acute eosinophilic pneumonia and performed broncho-alveolar lavage (BAL) about one month after onset. The proportion of eosinophils in BAL fluid was 72%. A second BAL was performed about 18 months after onset and BAL fluid included no eosinophils, despite the fact that he had continued CS.

Entities:  

Mesh:

Year:  2003        PMID: 14606718     DOI: 10.2169/internalmedicine.42.1016

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Clinical outcomes in patients with acute eosinophilic pneumonia not treated with corticosteroids.

Authors:  Byung Woo Jhun; Se Jin Kim; Rak Chae Son; Hongseok Yoo; Byeong-Ho Jeong; Man Pyo Chung; Kyeongman Jeon
Journal:  Lung       Date:  2015-03-28       Impact factor: 2.584

Review 2.  Cigarette smoking and diffuse lung disease.

Authors:  Rajesh R Patel; Jay H Ryu; Robert Vassallo
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Cigarettes-induced acute eosinophilic pneumonia: a case report.

Authors:  Leenhapong Navaravong; Kitsada Wudhikarn; John J Marini
Journal:  Cases J       Date:  2008-12-23

4.  Clinical Characteristics and Factors Influencing the Occurrence of Acute Eosinophilic Pneumonia in Korean Military Personnel.

Authors:  Chang-gyo Yoon; Se Jin Kim; Kang Kim; Ji Eun Lee; Byung Woo Jhun
Journal:  J Korean Med Sci       Date:  2016-01-26       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.